期刊
BMJ OPEN
卷 11, 期 1, 页码 -出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2020-043699
关键词
multiple sclerosis; rehabilitation medicine; sports medicine
资金
- Aarhus University, Faculty of Health (Aarhus C, DK)
- Trygfonden [123878]
- Augustinus fonden [17-2194]
- Danish MS Society Scleroseforeningen [A33634, A35468]
- Direktor Jacob Madsen og Hustru Olga Madsens Mindefond
- Knud og Edith Eriksens Mindefond
This study aims to investigate exercise as a supplementary treatment strategy early in the disease course of multiple sclerosis. The research is a 48-week (plus 1-year follow-up) national multicentre single-blinded parallel group randomized controlled trial comparing two groups receiving usual care plus supervised high-intense exercise or plus health education (active control).
IntroductionIn the relapsing remitting type of multiple sclerosis (MS) reducing relapses and neurodegeneration is crucial in halting the long-term impact of the disease. Medical disease-modifying treatments have proven effective, especially when introduced early in the disease course. However, patients still experience disease activity and disability progression, and therefore, supplemental early treatment strategies are warranted. Exercise appear to be one of the most promising supplemental treatment strategies, but a somewhat overlooked 'window of opportunity' exist early in the disease course. The objective of this study is to investigate exercise as a supplementary treatment strategy early in the disease course of MS.Methods and analysisThe presented Early Multiple Sclerosis Exercise Study is a 48-week (plus 1-year follow-up) national multicentre single-blinded parallel group randomised controlled trial comparing two groups receiving usual care plus supervised high-intense exercise or plus health education (active control). Additionally, data will be compared with a population-based control group receiving usual care only obtained from the Danish MS Registry. The primary outcomes are annual relapse rate and MRI derived global brain atrophy. The secondary outcomes are disability progression, physical and cognitive function, MS-related symptoms, and exploratory MRI outcomes. All analyses will be performed as intention to treat.Ethics and disseminationThe study is approved by The Central Denmark Region Committees on Health Research Ethics (1-10-72-388-17) and registered at the Danish Data Protection Agency (2016-051-000001 (706)). All study findings will be published in scientific peer-reviewed journals and presented at relevant scientific conferences.Trial registration numberNCT03322761.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据